Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
The Johns Hopkins University School of Medicine, Baltimore (United States of America)
3 More presentations in this session
Doctor N. Sawada (Tokyo, JP)
Doctor J. Du Fay De Lavallaz (Basel, CH)
Doctor A. Isath (Boston, US)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
You may be interested in
Congress Presentation
Congress Session
